Search Results

Viruses and neurodegeneration: a growing concern

• Authors : S. Shouman; N. Hesham; T. Z. Salem

Subjects: Neurodegenerative diseases (NDDs); Neuropathic infections; Neuroinflammation

• Source: Journal of Translational Medicine, Vol 23, Iss 1, Pp 1-21 (2025)

Record details

Improving the therapeutic efficacy of oncolytic viruses for cancer: targeting macrophages.

• Authors : Shen, Zhen^1,2 (AUTHOR); Liu, Xiyu¹ (AUTHOR); Fan, Guixiang^1,2 (AUTHOR)

• Source: Journal of Translational Medicine. 11/22/2023, Vol. 21 Issue 1, p1-14. 14p.

Record details

Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells.

• Authors : Victorio CBL; Laboratory for Translational and Molecular Imaging, Cancer and Stem Cell Biology Programme, Duke-NUS Medical School, Singapore, Singapore, 169857. .; Novera W

Subjects: Zika Virus*/Zika Virus*/Zika Virus*/physiology ; Oncolytic Viruses* ; Zika Virus Infection*/Zika Virus Infection*/Zika Virus Infection*/prevention & control

• Source: Journal of translational medicine [J Transl Med] 2024 Feb 02; Vol. 22 (1), pp. 126. Date of Electronic Publication: 2024 Feb 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Recent advances of engineered oncolytic viruses-based combination therapy for liver cancer.

• Authors : Zhang J; Institutes of Health Central Plains, Xinxiang Medical University, No. 601 Jinsui Road, Xinxiang, 453003, Henan Province, China. .; Henan Key Laboratory of Neurorestoratology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, 453100, China. .

Subjects: Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/genetics ; Oncolytic Virotherapy* ; Neoplasms*/Neoplasms*/Neoplasms*/genetics

• Source: Journal of translational medicine [J Transl Med] 2024 Jan 02; Vol. 22 (1), pp. 3. Date of Electronic Publication: 2024 Jan 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Optimizing viral transduction in immune cell therapy manufacturing: key process design considerations.

• Authors : Dan L; Bioprocessing Technology Institute BTI, Agency for Science, Technology and Research (A*STAR), 20 Biopolis Way, Singapore, 138668, Singapore. .; Kang-Zheng L

Subjects: Cell- and Tissue-Based Therapy*/Cell- and Tissue-Based Therapy*/Cell- and Tissue-Based Therapy*/methods ; Viruses*/Viruses*/Viruses*/genetics; Humans

• Source: Journal of translational medicine [J Transl Med] 2025 May 02; Vol. 23 (1), pp. 501. Date of Electronic Publication: 2025 May 02.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

IP6K2 mutations as a novel mechanism of resistance to oncolytic virus therapy.

• Authors : Huang Z; Department of Breast Surgical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, 350014, China.; Translational Chinese Medicine Key Laboratory of Sichuan Province, Sichuan-Chongqing Joint Key Laboratory of Innovation of New Drugs of Traditional Chinese Medicine, Sichuan Institute for Translational Chinese Medicine, Sichuan Academy of Chinese Medicine Sciences, Chengdu, 610041, China.

Subjects: Oncolytic Virotherapy* ; Mutation*/Mutation*/Mutation*/genetics ; Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/physiology

• Source: Journal of translational medicine [J Transl Med] 2025 Mar 12; Vol. 23 (1), pp. 311. Date of Electronic Publication: 2025 Mar 12.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Viruses belonging to Anelloviridae or Circoviridae as a possible cause of chronic fatigue.

• Authors : Grinde B; Division of Mental and Physical Health, Norwegian Institute of Public Health, Skøyen, PO Box 222, 0213, Oslo, Norway. .

Subjects: Anelloviridae* ; COVID-19* ; Circoviridae*

• Source: Journal of translational medicine [J Transl Med] 2020 Dec 14; Vol. 18 (1), pp. 485. Date of Electronic Publication: 2020 Dec 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis.

• Authors : Zhao JL; Department of Oncology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1 Minde Road, Nanchang, Jiangxi, China.; Lin BL

Subjects: Oncolytic Virotherapy*/Oncolytic Virotherapy*/Oncolytic Virotherapy*/methods ; Meningeal Neoplasms*/Meningeal Neoplasms*/Meningeal Neoplasms*/secondary ; Meningeal Neoplasms*/Meningeal Neoplasms*/Meningeal Neoplasms*/therapy

• Source: Journal of translational medicine [J Transl Med] 2024 Nov 05; Vol. 22 (1), pp. 1000. Date of Electronic Publication: 2024 Nov 05.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Trends and insights in dengue virus research globally: a bibliometric analysis (1995–2023).

• Authors : Liu, Yumeng¹ (AUTHOR) ; Wang, MengMeng² (AUTHOR); Yu, Ning² (AUTHOR)

• Source: Journal of Translational Medicine. 9/3/2024, Vol. 22 Issue 1, p1-15. 15p.

Record details

SARS-CoV-2 before and after Omicron: two different viruses and two different diseases?

• Authors : Renata Gili; Roberto Burioni

Subjects: COVID-19; Variant of concern; Omicron

• Source: Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-6 (2023)

Record details